113 related articles for article (PubMed ID: 8386927)
1. Lipopolysaccharide primes human alveolar macrophages for enhanced release of superoxide anion and leukotriene B4: self-limitations of the priming response with protein synthesis.
Suzuki K; Yamamoto T; Sato A; Murayama T; Amitani R; Yamamoto K; Kuze F
Am J Respir Cell Mol Biol; 1993 May; 8(5):500-8. PubMed ID: 8386927
[TBL] [Abstract][Full Text] [Related]
2. In vivo effect of lipopolysaccharide on alveolar and peritoneal macrophages of rats: superoxide anion generation and 5-lipoxygenase metabolism of arachidonic acid.
Takahashi H; Abe M; Hashimoto S; Takayama K; Miyazaki M
Am J Respir Cell Mol Biol; 1993 Mar; 8(3):291-8. PubMed ID: 8383509
[TBL] [Abstract][Full Text] [Related]
3. Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan.
Rankin JA; Sylvester I; Smith S; Yoshimura T; Leonard EJ
J Clin Invest; 1990 Nov; 86(5):1556-64. PubMed ID: 2173722
[TBL] [Abstract][Full Text] [Related]
4. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.
Stewart AG; Harris T; De Nichilo M; Lopez AF
Immunology; 1991 Feb; 72(2):206-12. PubMed ID: 1849872
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human alveolar macrophage production of leukotriene B4 by acute in vitro and in vivo exposure to tobacco smoke.
Tardif J; Borgeat P; Laviolette M
Am J Respir Cell Mol Biol; 1990 Feb; 2(2):155-61. PubMed ID: 2155016
[TBL] [Abstract][Full Text] [Related]
6. Depression of stimulated arachidonate metabolism and superoxide production in rat alveolar macrophages following in vivo exposure to 0.5 ppm NO2.
Robison TW; Murphy JK; Beyer LL; Richters A; Forman HJ
J Toxicol Environ Health; 1993 Mar; 38(3):273-92. PubMed ID: 8383773
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory and fibrotic mediator release by alveolar macrophages from coal miners.
Kuhn DC; Stauffer JL; Gaydos LJ; Demers LM
J Toxicol Environ Health; 1995 Sep; 46(1):9-21. PubMed ID: 7666496
[TBL] [Abstract][Full Text] [Related]
8. Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4.
Garcia JG; Griffith DE; Cohen AB; Callahan KS
Am Rev Respir Dis; 1989 Jun; 139(6):1494-501. PubMed ID: 2543249
[TBL] [Abstract][Full Text] [Related]
9. Altered release of eicosanoids by rat alveolar macrophages during granulomatous pulmonary inflammation.
Shellito J; Sniezek M
Am J Respir Cell Mol Biol; 1990 Mar; 2(3):289-96. PubMed ID: 2155633
[TBL] [Abstract][Full Text] [Related]
10. Regulation of nitric oxide release by macrophages after intratracheal lipopolysaccharide.
Shellito JE; Kolls JK; Summer WR
Am J Respir Cell Mol Biol; 1995 Jul; 13(1):45-53. PubMed ID: 7541222
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor increases leukotriene B4 release in stimulated alveolar macrophages from asthmatic patients.
Shindo K; Koide K; Fukumura M
Eur Respir J; 1998 May; 11(5):1098-104. PubMed ID: 9648962
[TBL] [Abstract][Full Text] [Related]
12. Enhanced production of nitric oxide by rat alveolar macrophages after inhalation of a pulmonary irritant is associated with increased expression of nitric oxide synthase.
Pendino KJ; Laskin JD; Shuler RL; Punjabi CJ; Laskin DL
J Immunol; 1993 Dec; 151(12):7196-205. PubMed ID: 7505023
[TBL] [Abstract][Full Text] [Related]
13. Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis.
De Rose V; Trentin L; Crivellari MT; Cipriani A; Gialdroni Grassi G; Pozzi E; Folco G; Semenzato G
Thorax; 1997 Jan; 52(1):76-83. PubMed ID: 9039241
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of human neutrophil and alveolar macrophage LTB4 production by N-acetylcysteine: role of hydrogen peroxide.
Dent G; Rabe KF; Magnussen H
Br J Pharmacol; 1997 Oct; 122(4):758-64. PubMed ID: 9375974
[TBL] [Abstract][Full Text] [Related]
16. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
Russell RE; Culpitt SV; DeMatos C; Donnelly L; Smith M; Wiggins J; Barnes PJ
Am J Respir Cell Mol Biol; 2002 May; 26(5):602-9. PubMed ID: 11970913
[TBL] [Abstract][Full Text] [Related]
17. Formation of lipoxins and leukotrienes by human alveolar macrophages incubated with 15(S)-HETE: a model for cellular cooperation between macrophages and airway epithelial cells.
Chavis C; Godard P; Crastes de Paulet A; Damon M
Eicosanoids; 1992; 5(3-4):203-11. PubMed ID: 1337977
[TBL] [Abstract][Full Text] [Related]
18. Human alveolar macrophages from smokers have an impaired capacity to secrete LTB4 but not other chemotactic factors.
Wieslander E; Linden M; Håkansson L; Eklund A; Blaschke E; Brattsand R; Venge P
Eur J Respir Dis; 1987 Oct; 71(4):263-72. PubMed ID: 2826202
[TBL] [Abstract][Full Text] [Related]
19. Complex effects of in vitro hyperoxia on alveolar macrophage arachidonic acid metabolism.
Sporn PH; Murphy TM; Peters-Golden M
Am J Respir Cell Mol Biol; 1990 Jan; 2(1):81-90. PubMed ID: 2155014
[TBL] [Abstract][Full Text] [Related]
20. A novel role of growth hormone and insulin-like growth factor-I. Priming neutrophils for superoxide anion secretion.
Fu YK; Arkins S; Wang BS; Kelley KW
J Immunol; 1991 Mar; 146(5):1602-8. PubMed ID: 1847167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
